Somatostatin receptor scintigraphy in the staging of small cell lung cancer

Nuclear Medicine Communications

Volumn 17, Issue 3, 1996, Pages 191-196

  Bohuslavizki, K H ^a   Brenner, W ^a   Gunther M ^b   Eberhardt, J U ^a   Jahn, N ^a   Tinnemeyer, S ^a   Wolf, H ^a   Sippel, C ^a   Clausen, M ^a   Gatzemeier, U ^b   Henze, E ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Clinic of Pneumonology and Oncology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; PENTETREOTIDE IN 111;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; LUNG SCINTISCANNING; LUNG SMALL CELL CANCER; MALE; METASTASIS;

EID: 9244255365     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006231-199603000-00003     Document Type: Article

References (46)

1. Koper JW, Markstein R, Kohler C, Kwekkeboom DJ, Avezaat CJJ, Lamberts SWJ, Reubi JC. Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth. J Clin Endocrinol Metab 1992; 74: 543-547.
2. Lamberts SWJ, Hofland LJ, van Koetsveld PM, Reubi JC, Bruining HA, Bakker WH, Krenning EP. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: Consequences with regard to diagnosis, localization, and therapy. J Clin Endocrinol Metab 1990; 72: 566-574.
3. Reubi JC, Laissue J, Krenning EP, Lamberts SWJ. Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Molec Biol 1992; 43: 27-35.
4. Reubi JC, Krenning EP, Lamberts SWJ, Kvols L. In vitro detection of somatostatin receptors in human tumors. Digestion 1993; 54 (suppl. 1): 76-83.
5. Reubi JC, Kvols L, Krenning EP, Lamberts SWJ. In vitro and in vivo detection of somatostatin receptors in human malignant tissue. Acta Ocol 1991; 30: 463-468.
6. 1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: Synthesis, radiolabeling and in vitro validation. Life Sci 1991; 49: 1583-1591.
7. Reubi JC, Waser B, van Hagen M, Lamberts SWJ, Krenning EP, Gebbers JO, Laissue JA. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancer 1992; 50: 895-900.
8. 11]somatostatin-14 to human small cell lung carcinoma (NCI-H69). Life Sci 1988; 43: 421-427.
9. Reubi JC, Waser B, Sheppard M, Macaulay V. Somatostatin receptors are present in small cell but not in non-small cell primary lung carcinomas: Relationship to EGF-receptors. Int J Cancer 1990; 45: 269-274.
10. O'Byrne KJ, Halmos G, Pinski J, Groot K, Szepeshazi K, Schally AV, Carney DN. Somatostatin receptor expression in lung cancer. Eur J Cancer 1994; 30A: 1682-1687.
11. 1]-octreotide for detection of somatostatin receptor-positive tumours in rats. Life Sci 1991; 49: 1593-1601.
12. Reubi JC, Maurer R, Klijn JGM, Stefanko SZ, Foekens JA, Blaauw G, Blankenstein MA, Lamberts SWJ. High incidence of somatostatin receptors in human meningiomas: Biochemical characterization. J Clin Endocrinol Metab 1986; 63: 433-438.
13. 3]-octreotide: The Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716-731.
14. Krenning EP, Breemann WAP, Kooij PPM, Lameris JS, Bakker WH, Koper JW, Ausema L, Reubi JC, Lamberts SWJ. Localisation of endocrine-related tumors with radioiodinated analogue of somatostatin. Lancet 1989; 333: 242-244.
15. Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Rev 1991; 12: 450-482.
16. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. Somatostatin-receptor imaging in the localization of endocrine tumors. New Engl J Med 1990; 323: 1246-1249.
17. Kwekkeboom DJ, Krenning EP, Bakker WJ, Oei HY, Kooij PPM, Lamberts SWJ. Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med 1993; 20: 283-292.
18. 111In-octreotide scintigraphy in oncology. Metabolism 1992; 9 (suppl. 2): 83-86.
19. 1]-octreotide scintigraphy in thyroidal and orbital Graves' disease: A parameter for disease activity? J Clin Endocrinol Metab 1994; 79: 1845-1851.
20. Kahaly G, Diaz M, Beyer J, Bockisch A. Indium-111-pentatreotide scintigraphy in Graves' opthalmopathy. J Nucl Med 1995; 36: 550-554.
21. 111In-octreotide imaging in patients with long-acting Graves' ophthalmopathy. Nucl Med Commun 1995; 16: 912-916.
22. Maini CL, Cioffi RP, Tofani A, Sciuto R, Fontana M, Carapella CM, Crecco M. In-111-octreotide scintigraphy in neurofibromatosis. Eur J Nucl Med 1995; 22: 201-206.
23. Scheidhauer K, Hildebrand G, Luyken C, Schomäcker K, Klug N, Schicha H. Somatostatin receptor scintigraphy in brain tumors and pituitary tumours: First experiences. Horm Metab Res 1993; 27: 59-62.
24. 111Indium-[DTPA-octreotide]-scintigraphy in meningioma patients. Acta Neurochir Wien 1994; 126: 63-71.
25. Maini CL, Tofani A, Sciuto R, Carapella C, Cioffi R, Crecco M. Scintigraphy visualization of somatostatin receptors in human meningiomas using 111-indium-DTPA-D-Phe-1-octreotide. Nucl Med Commun 1993; 14: 505-508.
26. 111In-octreotide. Nucl Med Commun 1995; 16: 756-766.
27. Bohuslavizki KH, Brenner W, Braunsdorf WEK, Behnke A, Tinnemeyer S, Hugo HH, Jahn N, Wolf H, Sippel C, Tönshoff G, Clausen M, Mehdorn HM, Henze E. Somatostatin receptor scintigraphy in differential diagnosis of meningioma (submitted).
28. Leitha T, Meghdadi S, Studnicka M, Wolzt M, Marosi C, Angelberger P, Neumann M, Schlick W, Kletter K, Dudzack R. The role of iodine-123-Tyr-3-octreotide scintigraphy in the staging of small-cell lung cancer. J Nucl Med 1993; 34: 1397-1402.
29. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Splinter TAW, Siang Kho G, Lamberts SWJ. Radioiodinated somatostatin analog scintigraphy in small-cell lung cancer. J Nucl Med 1991; 32: 1845-1848.
30. 111In-DTPA-octreotide: A preliminary study. Nucl Med Commun 1993; 14: 962-968.
31. Kwekkeboom DJ, Siang Kho G, Lamberts SWJ, Reubi JC, Laissue JA, Krenning EP. The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 1994; 21: 1106-1113.
32. 111In]pentatreotide, a radiolabelled somatostatin analogue. Br J Cancer 1994; 69: 762-766.
33. Kirsch CM, von Pawel J, Grau I, Tatsch K. Indium-111 pentatreotide in the diagnostic work-up of patients with bronchogenic carcinoma. Eur J Nucl Med 1994; 21: 1318-1325.
34. Bohuslavizki JU, Eberhardt JU, Günther M, Brenner W, Sippel C, Wolf H, Schramm M, Clausen M, Gatzemeier U, Henze E. Value of somatostatin receptor scintigraphy in staging of small cell lung cancer (abstract). Eur J Nucl Med 1995; 22: 845.
35. Reisinger I, Ketter B, Witt C, Ivancevic V. Somatostatin receptor scintigraphy (SRS) of small-cell lung cancer (SCLC) (abstract). Eur J Nucl Med 1995; 22: 845.
36. Schmidt S, Alexander C, Höfer M, Ukena D, Oberhausen E. Somatostatinrezeptorszintigraphie mit In-111-Octreoscan beim kleinzelligen Bronchialcarcinom (abstract). Nucl Med 1995; 34: A150.
37. Eberhardt JU, Günther M, Bohuslavizki KH, Brenner W, Sippel C, Clausen M, Gatzemeier U, Henze E. Stellenwert der Octreotid-Szintigraphie beim kleinzelligen Bronchialcarcinom im Vrgleich zu anderen bildgebenden Verfahren (abstract). Nucl Med 1995; 34: A151.
38. Ketter B, Reisinger I, John M, Witt C, Munz DL. Somatostatin-Rezeptor-Szintigraphie (SRS) beim kleinzelligen Bronchialcarcinom (abstract). Nucl Med 1995; 34: A151.
39. Macaulay VM, Smith IE, Everard MJ, Teale JD, Reubi JC, Millar JL. Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer. Br J Cancer 1994; 69: 451-156.
40. 11]somatostatin-14 to human small cell lung carcinoma (NCI-H69). Life Sci 1988; 43: 421-127.
41. Prevost G, Bourgeois Y, Mormont C, Lerrant Y, Veber N, Poupon MF, Thomas F. Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma xenograft: SCLC-6. Life Sci 1994; 55: 155-162.
42. Sachs L. Applied statistics: A handbook of techniques. Berlin: Springer, 1984.
43. Minna JD. Neoplasms of the lung. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's principles of internal medicine. New York: McGraw-Hill, 1994: 1221-1229.
44. McConachie NS, Worthington BS, Cornford EJ, Balsitis M, Kerslake RW, Jaspan T. Review article: Computed tomography and magnetic resonance in the diagnosis of intraventricular cerebral masses. Br J Radiol 1994; 67: 223-243.
45. Moretti JL, Caglar M, Boaziz C, Caillat-Vigneron N, Morere JF. Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: Can we predict the response to chemotherapy in a small cell lung cancer? Eur J Nucl Med 1995; 22: 177-180.
46. Soresi E, Liuzzi A, Barberis M, Gramegna G, Scoccia S, Boffi R, Borghini U, Schiraldi GF. Octreotide (OCT) therapy for lung cancers (LC) with neuroendocrine component (NE) (abstract). Eur Resp J 1992; 5 (suppl. 15): 447.